Natera Inc

For the period ended Dec 31, 2023. Filed Feb 29, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 29, 2024

NTRA$311.98-2.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Stockholders’ Equity

(in thousands)*


· · Common Stock · · AdditionalPaid-in · · · Accumulated Other Comprehensive · · Accumulated Deficit · · TotalStockholders'Equity
· Shares · Amount · Capital · · · Income (Loss) · ·
Balance as of December 31, 2020	86,223	$9	$1,411,286	$4,259	$(929,318)	$486,236
Issuance of common stock upon exercise of stock options	1,165	—	11,816	—	—	11,816
Issuance of common stock under employee stock purchase plan	186	—	13,550	—	—	13,550
Vesting of restricted stock	2,117	—	—	—	—	—
Stock-based compensation	—	—	115,219	—	—	115,219
Unrealized loss on available-for sale securities	—	—	—	(6,546)	—	(6,546)
Cumulative-effect adjustment upon adoption of ASU 2016-13	—	—	(82,876)	—	6,198	(76,678)
Issuance of common stock for public offering, net	5,175	1	550,821	—	—	550,822
Issuance of common stock for IPR&D acquisition	274	—	30,601	—	—	30,601
Net loss	—	—	—	—	(471,716)	(471,716)
Balance as of December 31, 2021	95,140	10	2,050,417	(2,287)	(1,394,836)	653,304
Issuance of common stock upon exercise of stock options	828	—	6,411	—	—	6,411
Issuance of common stock under employee stock purchase plan	437	—	13,037	—	—	13,037
Vesting of restricted stock	1,480	—	—	—	—	—
Stock-based compensation	—	—	152,384	—	—	152,384
Unrealized loss on available-for sale securities	—	—	—	(14,075)	—	(14,075)
Issuance of common stock for public offering, net	13,145	1	433,191	—	—	433,192
Issuance of common stock for IPR&D milestone	225	—	9,290	—	—	9,290
Net loss	—	—	—	—	(547,799)	(547,799)
Balance as of December 31, 2022	111,255	11	2,664,730	(16,362)	(1,942,635)	705,744
Issuance of common stock upon exercise of stock options	298	—	3,892	—	—	3,892
Issuance of common stock under employee stock purchase plan	392	—	15,128	—	—	15,128
Issuance of stock for bonuses	349	—	19,774	—	—	19,774
Issuance of common stock for IPR&D milestone	336	—	14,435	—	—	14,435
Issuance of common stock for public offering, net	4,550	—	235,441	—	—	235,441
Vesting of restricted stock units	2,401	—	—	—	—	-
Stock-based compensation	—	—	192,437	—	—	192,437
Unrealized gain on available-for sale securities	—	—	—	13,277	—	13,277
Net loss	—	—	—	—	(434,801)	(434,801)
Balance as of December 31, 2023	119,581	$11	$3,145,837	$(3,085)	$(2,377,436)	$765,327

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.